Research ArticleArticles

Coenzyme Q10 and Statin-Induced Mitochondrial Dysfunction

Richard Deichmann, Carl Lavie and Samuel Andrews
Ochsner Journal March 2010, 10 (1) 16-21;

REFERENCES

  1. ↵
    1. Litarru G. P.,
    2. Tiano L.
    (2007) Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol 37:31–37, pmid:17914161.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Siciliano G.,
    2. Volpi L.,
    3. Piazza S.,
    4. Ricci G.,
    5. Mancuso M.,
    6. Murri L.
    (2007) Functional diagnostics in mitochondrial diseases. Biosci Rep 27((1–3)):53–67, pmid:17492503.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Constantinescu R.,
    2. McDermott M. P.,
    3. DiCenzo R.,
    4. et al.
    (2007) A randomized study of the bioavailability of different formulations of coenzyme Q10 (ubiquinone). J Clin Pharmacol 47((12)):1580–1586, pmid:17925590, Epub 2007 Oct 9.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Littarru G. P.,
    2. Langsjoen P.
    (2007) Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion 7((suppl)):S168–S174, pmid:17482884, Epub 2007 March 27.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Rundek T.,
    2. Naini A.,
    3. Sacco R.,
    4. Coates K.,
    5. DiMauro S.
    (2004) Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 61((6)):889–992, pmid:15210526.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Ghirlanda G.,
    2. Oradei A.,
    3. Manto A.,
    4. et al.
    (1993) Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol 33((3)):226–229, pmid:8463436.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Lamperti C.,
    2. Naini A. B.,
    3. Lucchini V.,
    4. et al.
    (2005) Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol 62((11)):1709–1712, pmid:16286544.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Paiva H.,
    2. Thelen K. M.,
    3. Van Coster R.,
    4. et al.
    (2005) High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther 78((1)):60–68, pmid:16003294.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Laaksonen R.,
    2. Jokelainen K.,
    3. Laakso J.,
    4. et al.
    (1996) The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle. Am J Cardiol 77((10)):851–854, pmid:8623738.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Diebold B. A.,
    2. Bhagavan N. V.,
    3. Guillory R. J.
    (1994) Influences of lovastatin administration on the respiratory burst of leukocytes and the phosphorylation potential of mitochondria in guinea pigs. Biochim Biophys Acta 1200((2)):100–108, pmid:8031828.
    OpenUrlPubMed
  11. ↵
    1. Rosenfeldt F. L.,
    2. Pepe S.,
    3. Ou R.,
    4. et al.
    (1999) Coenzyme Q10 improves the tolerance of senescent myocardium to aerobic and ischemic stress: studies in rats and in human atrial tissue. BioFactors 9((2–4)):291–299, pmid:10416043.
    OpenUrlPubMed
  12. ↵
    1. Cooke M.,
    2. Iosia M.,
    3. Buford T.,
    4. et al.
    (2008) Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr 5:8, pmid:18318910.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Mizuno K.,
    2. Tanaka M.,
    3. Nozaki S.,
    4. et al.
    (2008) Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition 24((4)):293–299, pmid:18272335, Erratum in: Nutrition. 2008;24(6):616. Epub 2008 Feb 13.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Kon M.,
    2. Tanabe K.,
    3. Akimoto T.,
    4. et al.
    (2008) Reducing exercise-induced muscular injury in kendo athletes with supplementation of coenzyme Q10. Br J Nutr 100((4)):903–909, pmid:18284711, Epub 2008 Feb 20.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Ylikoski T.,
    2. Piirainen J.,
    3. Hanninen O.,
    4. Pentinnen J.
    (1997) The effect of coenzyme Q10 on the exercise performance of cross-country skiers. Mol Aspects Med 18((suppl)):283–290.
    OpenUrl
  16. ↵
    1. Folkers K.,
    2. Littarru G. P.,
    3. Yamagami T.
    1. Amadio E.,
    2. Palermo R.,
    3. Peloni G.,
    4. et al.
    (1991) in Biomedical and Clinical Aspects of Coenzyme Q10, Effect of CoQ10 administration on VO2max and diastolic function in athletes, eds Folkers K., Littarru G. P., Yamagami T. (Elsevier Science, New York, NY), pp 513–520.
  17. ↵
    1. Morisco C.,
    2. Trimarco B.,
    3. Condorelli M.
    (1993) Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig 71((8)):S134–S136.
    OpenUrlPubMedWeb of Science
  18. ↵
    1. Snider I. P.,
    2. Bazzarre T. L.,
    3. Murdoch S. D.,
    4. Goldfarb A.
    (1992) Effects of coenzyme athletic performance system as an ergogenic aid on endurance performance to exhaustion. Int J Sport Nutr 2((3)):272–286, pmid:1338584.
    OpenUrlPubMedWeb of Science
  19. ↵
    1. Laaksonen R.,
    2. Fogelholm M.,
    3. Himberg J. J.,
    4. Laakso J.,
    5. Salorinne Y.
    (1995) Ubiquinone supplementation and exercise capacity in trained young and older men. Eur J Appl Physiol 72((1–2)):95–100.
    OpenUrl
  20. ↵
    1. Rosenfeldt F.,
    2. Hilton D.,
    3. Pepe S.,
    4. Krum H.
    (2003) Systemic review of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 18((1–4)):91–100, pmid:14695924.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Marcoff L.,
    2. Thompson P. D.
    (2007) The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol 49((23)):2231–2237, pmid:17560286.
    OpenUrlFREE Full Text
  22. ↵
    1. Mizuno M.,
    2. Quistorff B.,
    3. Theorell H.,
    4. Theorell M.,
    5. Chance B.
    (1997) Effects of oral supplementation of coenzyme Q10 on P-NMR detected skeletal muscle energy metabolism in middle-aged post-polio subjects and normal volunteers. Mol Aspects Med 18((suppl)):S291–S298, pmid:9266539.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Chan A.,
    2. Reichmann H.,
    3. Kögel A.,
    4. Beck A.,
    5. Gold R.
    (1998) Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy. J Neurol 245((10)):681–685, pmid:9776469.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Milani R. V.,
    2. Lavie C. J.,
    3. Mehra M. R.,
    4. Ventura H. O.
    (2006) Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc 81((12)):1603–1611, pmid:17165639.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Harries M.,
    2. Williams C.,
    3. Stanish W. D.,
    4. et al.
    (1998) Oxford Textbook of Sports Medicine. 2nd ed (Oxford University Press, New York, NY).
  26. ↵
    1. Kon M.,
    2. Kimura F.,
    3. Akimoto T.,
    4. et al.
    (2007) Effect of Coenzyme Q10 supplementation on exercise-induced muscular injury of rats. Exerc Immunol Rev 13:76–88, pmid:18198662.
    OpenUrlPubMed
  27. ↵
    1. Maroo B. P.,
    2. Lavie C. J.,
    3. Milani R. V.
    (2008) Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike? Drugs Aging 25((8)):649–664, pmid:18665658.
    OpenUrlPubMed
  28. ↵
    1. Maroo B. P.,
    2. Lavie C. J.,
    3. Milani R. V.
    (2008) Efficacy and safety of intensive statin therapy in the elderly. Am J Geriatr Cardiol 17((2)):92–100, pmid:18326948.
    OpenUrlPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords